ABT stock verdict - Avoid
ABT
Abbott Laboratories
AVOIDHealthcare
$104.49
Fundamentals below bar
$104.49
Heavy$47.30Buy$63.07Fair$78.84Exit$94.61
FUNDAMENTAL48
TECHNICAL80
TRUST SCORE
30Very Low
confidence in this read — data completeness, earnings quality & coverage
Uptrend · EMA20 96.41 · EMA50 94.27 · EMA200 105.16 · RSI 67.7 · MACD above signal
PROS
- Revenue grew 13.0%/yr on average over the last 3 years
- High gross margin of 57% (3-yr avg)
- Price is in an uptrend — above key moving averages with positive momentum
CONS
- Trades above the model's exit level ($94.61) — overvalued on this framework
✳ Pros and cons are machine-generated from the latest fundamentals and technicals.
SECTOR PEERS
Analysis as of 2026-07-28 · price live, fundamentals from latest filings
FAQ
Why is ABT rated Avoid?
ABT (Abbott Laboratories) is rated Avoid because the model combines fundamentals, price action, and earnings-quality checks. The current signal is Fundamentals below bar. Revenue grew 13.0%/yr on average over the last 3 years and High gross margin of 57% (3-yr avg)
Is ABT overvalued right now?
ABT is trading at $104.49 versus an estimated fair value of $78.84. That puts the stock in avoid territory on this framework. Trades above the model's exit level ($94.61) — overvalued on this framework
What should I watch before acting on ABT?
Watch the trust score of 30, the earnings-quality checks, and any red flags. Trades above the model's exit level ($94.61) — overvalued on this framework